Analyst Research

Report Title Price
Provider : Stock Traders Daily
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Boston Scientific Corp Receives Approval For Alair Bronchial Thermoplasty System In China


Wednesday, 23 Oct 2013 04:30pm EDT 

Boston Scientific Corporation announced that it has received China Food and Drug Administration approval for the Alair Bronchial Thermoplasty System, a medical device designed to treat severe asthma. Expected to be available in the China market later this year, the Alair System provides therapy for patients with severe asthma which is not well controlled with inhaled corticosteroids and long-acting beta-agonists.